A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing

BACKGROUND: Guidelines for genetic testing for BRCA1 or BRCA2 stipulate that a personal or family history of cancer is necessary to be eligible for testing. Approximately 2% of Ashkenazi Jewish women carry a mutation, but to date population-based testing has not been advocated. Little is known about...

Descripción completa

Detalles Bibliográficos
Autores principales: Metcalfe, K A, Poll, A, Royer, R, Nanda, S, Llacuachaqui, M, Sun, P, Narod, S A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738109/
https://www.ncbi.nlm.nih.gov/pubmed/23778531
http://dx.doi.org/10.1038/bjc.2013.309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738109/
https://www.ncbi.nlm.nih.gov/pubmed/23778531
http://dx.doi.org/10.1038/bjc.2013.309

Ejemplares similares